Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is This Healthcare Giant a Buy for Dividend Growth Investors?


Chances are, if you're reading this article, you are aiming to be a successful long-term investor. And if you want to do well at investing, there are arguably two things you should do. First, pick an investing strategy you can execute through thick and thin. And second, find a role model you can emulate. 

As a dividend growth investor, I am most focused on selecting great businesses with dependable profits. And this is largely the same strategy as the chairman and CEO of Berkshire Hathaway, Warren Buffett.

With a stake in the healthcare products distributor known as McKesson (NYSE: MCK) valued at $1.2 billion, the Oracle of Omaha seems to be impressed with the stock. But should you buy it for your portfolio? Let's take a closer look at McKesson's fundamentals and valuation to address this question. 

Continue reading


Source Fool.com

Like: 0
MCK
Share

Comments